BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

239 related articles for article (PubMed ID: 12851694)

  • 1. Advanced indications for gonadotropin-releasing hormone (GnRH) analogues in gynecological oncology (review).
    Sugiyama M; Imai A; Takahashi S; Hirano S; Furui T; Tamaya T
    Int J Oncol; 2003 Aug; 23(2):445-52. PubMed ID: 12851694
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Chemotherapy-induced female infertility and protective action of gonadotropin-releasing hormone analogues.
    Imai A; Furui T
    J Obstet Gynaecol; 2007 Jan; 27(1):20-4. PubMed ID: 17365452
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Luteinizing hormone-releasing hormone receptor-targeted chemotherapy using AN-152.
    Emons G; Sindermann H; Engel J; Schally AV; Gründker C
    Neuroendocrinology; 2009; 90(1):15-8. PubMed ID: 19521066
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Gonadotropin-releasing hormone type II antagonists induce apoptotic cell death in human endometrial and ovarian cancer cells in vitro and in vivo.
    Fister S; Günthert AR; Emons G; Gründker C
    Cancer Res; 2007 Feb; 67(4):1750-6. PubMed ID: 17308117
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Increase of doxorubicin-induced apoptosis after knock-down of gonadotropin-releasing hormone receptor expression in human endometrial, ovarian and breast cancer cells.
    Fister S; Schlotawa L; Günthert AR; Emons G; Gründker C
    Gynecol Endocrinol; 2008 Jan; 24(1):24-9. PubMed ID: 17943530
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Gonadotropin-releasing hormone and ovarian cancer: a functional and mechanistic overview.
    So WK; Cheng JC; Poon SL; Leung PC
    FEBS J; 2008 Nov; 275(22):5496-511. PubMed ID: 18959739
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A clinician's guide to the use of gonadotropin-releasing hormone analogues in women.
    Moghissi KS
    Medscape Womens Health; 2000 Jan; 5(1):5. PubMed ID: 10792849
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Targeted chemotherapy of endometrial, ovarian and breast cancers with cytotoxic analogs of luteinizing hormone-releasing hormone (LHRH).
    Engel JB; Schally AV; Buchholz S; Seitz S; Emons G; Ortmann O
    Arch Gynecol Obstet; 2012 Aug; 286(2):437-42. PubMed ID: 22555802
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effective treatment of experimental human endometrial cancers with targeted cytotoxic luteinizing hormone-releasing hormone analogues AN-152 and AN-207.
    Engel JB; Keller G; Schally AV; Nagy A; Chism DD; Halmos G
    Fertil Steril; 2005 Apr; 83 Suppl 1():1125-33. PubMed ID: 15831285
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Intratumoral level of gonadotropin-releasing hormone in ovarian and endometrial cancers.
    Furui T; Imai A; Tamaya T
    Oncol Rep; 2002; 9(2):349-52. PubMed ID: 11836606
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Peptidomimetic GnRH antagonist AEZS-115 inhibits the growth of ovarian and endometrial cancer cells.
    Engel JB; Hahne JC; Häusler SF; Meyer S; Segerer SE; Diessner J; Dietl J; Honig A
    Anticancer Res; 2012 May; 32(5):2063-8. PubMed ID: 22593489
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Targeting of cytotoxic luteinizing hormone-releasing hormone analogs to breast, ovarian, endometrial, and prostate cancers.
    Nagy A; Schally AV
    Biol Reprod; 2005 Nov; 73(5):851-9. PubMed ID: 16033997
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Indications of GnRH analogues before and after surgery for endometriosis].
    Daraï E; Dubernard G; Azoulay C; Barranger E; Antoine JM; Uzan S
    Gynecol Obstet Fertil; 2005 Dec; 33(12):1014-7. PubMed ID: 16311060
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Gonadotropin-releasing hormone type II induces apoptosis of human endometrial cancer cells by activating GADD45alpha.
    Wu HM; Cheng JC; Wang HS; Huang HY; MacCalman CD; Leung PC
    Cancer Res; 2009 May; 69(10):4202-8. PubMed ID: 19366794
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Gonadotropin-releasing hormone analogs].
    Krysiak R; Okopień B; Herman ZS
    Pol Merkur Lekarski; 2005 May; 18(107):585-9. PubMed ID: 16161962
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Development of novel 68Ga- and 18F-labeled GnRH-I analogues with high GnRHR-targeting efficiency.
    Schottelius M; Berger S; Poethko T; Schwaiger M; Wester HJ
    Bioconjug Chem; 2008 Jun; 19(6):1256-68. PubMed ID: 18510351
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [GnRH analogs in gynecology. Possibilities for therapeutic use].
    Niesert S
    Fortschr Med; 1990 Sep; 108(26):498-500. PubMed ID: 2262188
    [TBL] [Abstract][Full Text] [Related]  

  • 18. GnRH-analogues and oral contraceptives for fertility preservation in women during chemotherapy.
    Blumenfeld Z; von Wolff M
    Hum Reprod Update; 2008; 14(6):543-52. PubMed ID: 18824495
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Novel therapeutic strategies for endometriosis: a pathophysiological perspective.
    Osuga Y
    Gynecol Obstet Invest; 2008; 66 Suppl 1():3-9. PubMed ID: 18936546
    [TBL] [Abstract][Full Text] [Related]  

  • 20. GnRH-antagonists in reproductive medicine.
    Griesinger G; Felberbaum R; Diedrich K
    Arch Gynecol Obstet; 2005 Dec; 273(2):71-8. PubMed ID: 15991015
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.